Urinary rubidium in breast cancers

Clinica Chimica Acta

Volumn 412, Issue 23-24, 2011, Pages 2305-2309

  Su, Yi ^a   Chen, Li Juan ^a   He, Jian Rong ^a   Yuan, Xue Jiao ^a   Cen, Yu Ling ^a   Su, Feng Xi ^b   Tang, Lu Ying ^a,c   Zhang, Ai Hua ^d   Chen, Wei Qing ^a   Lin, Ying ^e   Wang, Shen Ming ^e   Ren, Ze Fang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^d Guangdong Prevention and Treatment Center for Occupational Diseases   (China)

^e THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Association; Breast cancer; Risk assessment; Rubidium; Urine

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; RUBIDIUM;

ADULT; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK REDUCTION; URINE LEVEL;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CREATININE; FEMALE; HUMANS; MIDDLE AGED; RUBIDIUM;

EID: 80053632500     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.08.035     Document Type: Article

References (41)

1. Wang W., Srivastava S. Strategic approach to validating methylated genes as biomarkers for breast cancer. Cancer Prev Res (Phila) 2010, 3:16-24.
2. Mealiffe M.E., Stokowski R.P., Rhees B.K., Prentice R.L., Pettinger M., Hinds D.A. Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information. J Natl Cancer Inst 2010, 102:1618-1627.
3. Gail M.H. Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst 2008, 100:1037-1041.
4. Gail M.H. Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model. J Natl Cancer Inst 2009, 101:959-963.
5. Wacholder S., Hartge P., Prentice R., et al. Performance of common genetic variants in breast-cancer risk models. N Engl J Med 2010, 362:986-993.
6. Lichtenstein P., Holm N.V., Verkasalo P.K., et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000, 343:78-85.
7. Rudel R.A., Attfield K.R., Schifano J.N., Brody J.G. Chemicals causing mammary gland tumors in animals signal new directions for epidemiology, chemicals testing, and risk assessment for breast cancer prevention. Cancer 2007, 109:2635-2666.
8. Cazzaniga M., Decensi A., Bonanni B., Luini A., Gentilini O. Biomarkers for risk assessment and prevention of breast cancer. Curr Cancer Drug Targets 2009, 9:482-499.
9. Calloway D.R., Glaque R.D., Costa F.N. The superior mineral content of some Amencan Indian food, in comparison to Federal donated counterpart commodities. Ecol Food Nutr 1974, 3:203-210.
10. Brewer A.K., Clarke B.J., Greenberg M., Rothkopf N. The effects of rubidium on mammary tumor growth in C57 blk/6J mice. Cytobios 1979, 24:99-101.
11. Drake E.N., Sky-Peck H.H. Discriminant analysis of trace element distribution in normal and malignant human tissues. Cancer Res 1989, 49:4210-4215.
12. Ng K.H., Ong S.H., Bradley D.A., Looi L.M. Discriminant analysis of normal and malignant breast tissue based upon INAA investigation of elemental concentration. Appl Radiat Isot 1997, 48:105-109.
13. Rizk S.L., Sky-Peck H.H. Comparison between concentrations of trace elements in normal and neoplastic human breast tissue. Cancer Res 1984, 44:5390-5394.
14. Ebrahim A.M., Eltayeb M.A., Shaat M.K., Mohmed N.M., Eltayeb E.A., Ahmed A.Y. Study of selected trace elements in cancerous and non-cancerous human breast tissues from Sudanese subjects using instrumental neutron activation analysis. Sci Total Environ 2007, 383:52-58.
15. Tamano H., Enomoto S., Oku N., Takeda A. Preferential uptake of zinc, manganese, and rubidium in rat brain tumor. Nucl Med Biol 2002, 29:505-508.
16. Zaichick V., Tsyb A.F., Vtyurin B.M. Trace elements and thyroid cancer. Analyst 1995, 120:817-821.
17. Garg A.N., Singh V., Weginwar R.G., Sagdeo V.N. An elemental correlation study in cancerous and normal breast tissue with successive clinical stages by neutron activation analysis. Biol Trace Elem Res 1994, 46:185-202.
18. Paschalis C., Jenner F.A., Lee C.R. Effects of rubidium chloride on the course of manic-depressive illness. J R Soc Med 1978, 71:343-352.
19. Fieve R.R., Meltzer H.L., Taylor R.M. Rubidium chloride ingestion by volunteer subjects: initial experience. Psychopharmacologia 1971, 20:307-314.
20. Hammond M.E., Hayes D.F., Dowsett M., et al. American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 2010, 28:2784-2795.
21. Wolff A.C., Hammond M.E., Schwartz J.N., et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007, 25:118-145.
22. Barr D.B., Wilder L.C., Caudill S.P., Gonzalez A.J., Needham L.L., Pirkle J.L. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 2005, 113:192-200.
23. Stephan C., Wesseling S., Schink T., Jung K. Comparison of eight computer programs for receiver-operating characteristic analysis. Clin Chem 2003, 49:433-439.
24. Park S.H., Goo J.M., Jo C.H. Receiver operating characteristic (ROC) curve: practical review for radiologists. Korean J Radiol 2004, 5:11-18.
25. Swets J.A. Measuring the accuracy of diagnostic systems. Science 1988, 240:1285-1293.
26. Shenberg C., Feldstein H., Cornelis R., et al. Br, Rb, Zn, Fe, Se and K in blood of colorectal patients by INAA and PIXE. J Trace Elem Med Biol 1995, 9:193-199.
27. Monroe S.H. Anti-cancer formulation. United States Patent Application Publication 2004, 1-2. Greystone Medical Group, Inc, Memphis, TN: USA.
28. Brewer A.K. The high pH therapy for cancer tests on mice and humans. Pharmacol Biochem Behav 1984, 21:1-5.
29. Anke M., Angelow L. Rubidium in the food chain. Fresenius J Anal Chem 1995, 352:236-239.
30. Centers for Disease control and Prevention (CDC), National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data (NHANES) 2003-2004, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Hyattsville, MD, [accessed 2010 Dec 27]. Available from:. http://www.cdc.gov/nchs/.
31. Heitland P., Koster H.D. Biomonitoring of 30 trace elements in urine of children and adults by ICP-MS. Clin Chim Acta 2006, 365:310-318.
32. Lof M., Weiderpass E. Impact of diet on breast cancer risk. Curr Opin Obstet Gynecol 2009, 21:80-85.
33. Lee S.A., Kang D., Nishio H., et al. Methylenetetrahydrofolate reductase polymorphism, diet, and breast cancer in Korean women. Exp Mol Med 2004, 36:116-121.
34. Baglietto L., Krishnan K., Severi G., et al. Dietary patterns and risk of breast cancer. Br J Cancer 2011, 104:524-531.
35. Gail M.H., Brinton L.A., Byar D.P., et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989, 81:1879-1886.
36. Rockhill B., Spiegelman D., Byrne C., Hunter D.J., Colditz G.A. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 2001, 93:358-366.
37. Gail M.H., Mai P.L. Comparing breast cancer risk assessment models. J Natl Cancer Inst 2010, 102:665-668.
38. Chen Z., Zheng W., Custer L.J., et al. Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai. Nutr Cancer 1999, 33:82-87.
39. Wacholder S., Chatterjee N., Hartge P. Joint effect of genes and environment distorted by selection biases. Cancer Epidemiol Biomarkers Prev 2002, 11:885-889.
40. Wacholder S., Silverman D.T., McLaughlin J.K., Mandel J.S. Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol 1992, 135:1029-1041.
41. Schlesselman J.J. Assessing effects of confounding variables. Am J Epidemiol 1978, 108:3-8.